Alzheimer’s Association Launches ALZ-NET Real-World Data Network

The Alzheimer’s Association has announced a new collaboration to advance research and care for people living with Alzheimer’s disease. The Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) will help researchers collect and analyze real-world data (RWD) that comes from newly FDA-approved Alzheimer’s therapeutics. The network will also include resources to promote clinical readiness for new therapies

According to Ken Downey Jr., “Patients starting or currently receiving treatment with a novel FDA-approved therapy for AD may enroll in ALZ-NET, which will monitor long-term patient health outcomes, response to therapy and adverse events. Patient data collected includes baseline demographic, medical, neurologic, genetic and biomarker information.”

To read more, click here.

(Source: Healio News, December 6^th, 2022)